Tocagen's Series E Round

Tocagen raised a round of funding on January 04, 2011.

Tocagen is a clinical-stage biopharmaceutical company pursuing the discovery, development, and commercialization of products for the treatment of cancer. Tocagen is initially focusing on treatments fo…

Articles about Tocagen's Series E Round: